Hypoxia plays a critical role in physiologically normal development such as embryogenesis, in which embryo is in a state of partial hypoxia, which is essential for the control of neovascular and cardiovascular development. Hypoxia also plays pathophysiological roles in human diseases such as ischemia, stroke and cancer [1][2][3] 
Introduction

Hypoxia plays a critical role in physiologically normal development such as embryogenesis, in which embryo is in a state of partial hypoxia, which is essential for the control of neovascular and cardiovascular development. Hypoxia also plays pathophysiological roles in human diseases such as ischemia, stroke and cancer [1-3]. For example, tumour cells exhibit molecular adaptation to oxygen deprivation via initiation of hypoxia-mediated survival pathways, angiogenesis, erythropoiesis, invasion and metastasis.
Ultimately, prolonged hypoxic stress leads to a more aggressive tumour phenotype that is less sensitive to both radiation and chemotherapy [4] . Several lines of independent studies have shown that hypoxia is an indicator of poor prognosis for patients with breast [5] [6] [7] , cervical [8] [9] [10] and non-small cell lung cancers [11] , independent of other clinical factors such as tumour size.
Another important feature of tumour growth is the unregulated receptor tyrosine kinase (RTK) activity through constitutive mutational activation, overexpression or defective termination of RTKmediated signalling [12-17]. Although there have been hypoxiadependent transcriptional and translational mechanisms described for the enhancement of certain RTK expression, a general unifying mechanism governing hypoxia-induced RTK signalling has been until recently unknown. This review highlights recent discoveries into the causal role of tumour hypoxia in the regulation of RTK and non-RTK endocytosis and the contribution of these hypoxia-adaptive processes to cancer development.
Hypoxia-inducible factors
The hypoxic response is orchestrated by the hypoxia-inducible factor (HIF), a heterodimeric transcription factor consisting of a modular ␣ and a common ␤ subunit, the aryl hydrocarbon receptor nuclear translocator (ARNT) [18] [19] [20] [21] [41] .
In contrast, pinocytosis is the ingestion of small particles (Ͻ0.2 m) such as extracellular fluid and dissolved molecules [42, 43] .
Also referred to as cellular 'drinking', pinocytosis is a process that occurs in all cell types and is mechanistically diverse and highly regulated. Macropinocytosis is a subset of actin-dependent pinocytic process regulated by the Rho family GTPase Rac1. Actin polymerization drives the formation of membrane ruffles and protrusions that collapse back onto and fuse with the plasma membrane, which generates large endocytic vesicles of variable size called macropinosomes that contain large volumes of fluid.
Although the mechanics behind this highly regulated process are not well understood, growth factor-induced macropinocytosis may play a role in directed cell migration and cancer metastasis [44] .
Clathrin-mediated endocytosis
Clathrin-mediated endocytosis (CME) is the best-characterized endocytic pathway. CME is triggered by the binding of ligand to its cognate receptor and occurs in two stages divided into multiple
steps [45, 46] [47] . CME is also a highly selective process and at least two types of internalization signal have been described: the tyrosine-based motif (YXX⌽, in which ⌽ is a hydrophobic residue) and the dileucinebased motif (LL) [48] [49] [50] [51] .
Once a clathrin-coated vesicle is severed from the membrane, these vesicles lose their clathrin coat, merge with early endosomes and sorted, either to be recycled to the plasma membrane or to be targeted to the lysosome [52] . For example, following its rapid internalization to the early sorting endosomes, the transferrin receptor, a well-studied clathrin cargo, is returned to the plasma membrane [53] . [51, 54] .
Other receptors, such as the epidermal growth factor receptor (EGFR), are primarily destined for late endosomes and ultimately lysosomes where the receptors and ligands are degraded in the acidic milieu containing digestive enzymes (acid hydrolases)
Intracellular trafficking of receptors involves a series of membrane budding and fusion events [55] . These are regulated by specific cytosolic and membrane-associated protein factors, including a group of Ras-like small GTPases called Rabs [56] . The current view is that Rabs are involved in specifying the correctness of membrane-membrane interactions at either the docking or fusion level or both [57] . For example, Rab4 and Rab11 control the function and formation of endosomes involved in recycling while Rab7 regulates membrane transport from the early endosomal stage through to the late endosomal and lysosomal stages. Rab5 controls membrane trafficking in the early endocytic pathway, thereby dictating the sorting function in endocytosis [57] . Rabaptin-5 is one of the most well-characterized Rab5 effectors having two Rab5 binding sites, which suggests that rabaptin-5 plays a role in the tethering of early endosomes [58] . Rabaptin-5 also has an Nterminal Rab4 binding domain, which suggests that it has a role in endosome recycling [59] . Early endosomal antigen 1 (EEA1) is another Rab5 effector [60] . EEA1 is also involved in the tethering/docking and fusion of early endosomes and contains two Rab5 binding sites, as well as a C-terminal FYVE domain that specifically binds to phosphatidylinositol 3-phosphate (PI3P) [61] .
Clathrin-independent endocytosis
Endocytosis of membrane and fluid also occurs through a clathrin-independent pathway. Clathrin-independent endocytosis can be distinguished from CME by its slow kinetic characteristics, as opposed to the rapid internalization that occurs via CME. [69, 70] .
In addition to caveolin-mediated endocytosis, caveolinindependent pathways represent a rapidly evolving field of study. The molecular details of how vesicles are formed and how these pathways are regulated are not well understood [71] . Advances in our understanding of these pathways come primarily from the identification of cargo molecules internalized through non-clathrin pathways and the identification of possible regulators [72] . Using regulators as a basis for categorization, clathrin-and caveolinindependent pathways can be grouped into RhoA-dependent [73] , Cdc42-dependent [74] and Arf6-dependent types [75] . However, this approach has not been entirely satisfactory. There is still disagreement about how many of these clathrin-independent pathways exist and confusion about how they may overlap mechanistically and functionally. Adding to the confusion or complexity is the fact that many cargos can be internalized through multiple pathways. This is perhaps best illustrated by differences in the endocytosis of EGFR. Although EGFR is internalized through CME at low physiological concentrations of EGF, EGFR may be internalized by caveolin-mediated endocytosis at higher ligand concentrations [76, 77] . [80] . EGFR regulates HIF-␣ expression through the PI3K-Akt signalling axis in non-small cell lung cancer [81] [82] [83] . The crosstalk between EGFR and HIF signalling pathways has been reported to increase resistance to apoptosis under normoxic conditions in human breast cancer cells [84] .
Hypoxia-mediated regulation of RTKs
Other studies have shown that tumour hypoxia can up-regulate signalling via the hepatocyte growth factor (HGF)/c-Met pathway as well [85] . [89] . [90] . [91] [92] . Integrin dysfunction is a common event in cancer development, especially in metastasis and cancer invasion. Integrins are internalized through both CME and clathrin-independent endocytosis [93] . [94] . Hypoxia-stimulated Rab11c (also called Rab25) was shown to directly associate with integrin ␣5␤1, which enables a pool of the recycling integrins to be retained at the cell front, promoting invasion into fibroblast-derived ECM [95] . Clinically relevant is that Rab11c has been found to be overexpressed in more than 50% of ovarian and breast cancers and is associated with shorter survival [96] . These findings suggest that hypoxia-mediated recycling of integrins by Rab11 plays an important agonistic role in tumour progression and invasion. [97] . In alveolar epithelial cells, acute hypoxia promotes Na,K-ATPase endocytosis, resulting in the inhibition of Na,K-ATPase activity [98] [99] [100] . Prolonged hypoxia leads to RhoA-dependent degradation of plasma membrane Na,KATPase [99] and intriguingly, occurs only in the presence of VHL [100] . The overexpression of Na,K-ATPase has been associated with the development of prostate cancer [101] and colorectal cancer [102] . These findings support the notion that hypoxia-mediated Na,K-ATPase endocytosis is involved in cancer development.
HGF normally stimulates growth, migration and epithelial-to-mesenchymal transition in a range of cell types, including epithelial, blood, neural and skin cells as well as hepatocytes [86]. Pennacchietti et al. revealed that under hypoxic cell culture conditions, c-Met, the receptor for HGF, is increased at both the transcription and protein levels, thus making it more available for ligation with HGF [87]. Under hypoxia, increased c-Met expression and HGF sensitization promote tumour cell invasiveness [87, 88]. Moreover, hypoxia has also been shown to induce tyrosine phosphorylation of the platelet-derived growth factor receptor, activate PI3K/Akt cascade that leads to glycogen synthase kinase-3 inactivation, and enhance vascular endothelial growth factor receptor expression
Hypoxia-mediated RTK endocytosis
Hsu et al. provided evidence that VHL -/-RCC cells exhibit increased surface abundance of fibroblast growth factor receptor 1 upon ligand stimulation and downstream target activation, such as ERK1/2, compared to VHL-reconstituted RCC counterpart
VHL was shown to interact with the metastasis suppressor Nm23, a protein known to regulate dynamin-dependent endocytosis at the level of internalization, suggesting that VHL promotes internalization process of fibroblast growth factor receptor 1 [90]. Whether hypoxia influenced RTK turnover upon ligand engagement was, until recently, unknown. Yi et al. asked whether the common observation of tumour hypoxia and RTK overexpression in solid tumours were causally linked, and revealed that hypoxia or loss of VHL prolonged EGFR half-life through HIF-mediated delay of endosome formation and the eventual degradation of EGFR cargo in lysosomes
Yoon et al. recently demonstrated that hypoxia stimulates Rab11-mediated recycling of integrin ␣6␤4-containing vesicles to the plasma membrane [94]. This function is thought to be important in cell invasion since overexpression of a dominant-negative form of Rab11 blocks hypoxia-induced invasion
Hypoxia-mediated Na,K-ATPase endocytosis
Down-regulation of Na,K-ATPase, an ATP-dependent ion pumping system, via endocytosis is associated with the metastatic behaviour of several cancers
p38 MAPK in hypoxia-mediated endocytosis
p38 MAPK is well known stress-activated MAPK and an important regulator of cancer progression [103] . [104, 105] . p38 MAPK is also required for phagolysosome biogenesis and the endocytosis of the ␣-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor [104, 106] . p38 MAPK phosphorylates and activates the Rab GDP dissociation inhibitor (RabGDI), which enhances its inhibitory activity toward Rab5, attenuating or terminating the endocytic process [104] . Given that p38 MAPK responds to a wide range of stimuli, including hypoxia [107] , it is reasonable to predict that p38 MAPK modulates hypoxia-mediated endocytosis.
Several lines of evidence suggest a role of p38 MAPK in endocytosis. For example, p38 MAPK controls the endocytic trafficking of various growth-related cell surface receptors and transporters through its ability to phosphorylate EEA1 at Thr1392, thus blocking EEA1-mediated homotypic fusion and subsequent accumulation of early endosomes
Concluding remarks
The cellular sorting machinery, which displays many genetic and post-translational alterations in tumours, is regulated by oxygen tension. The current and aforementioned view of hypoxia-regulated endocytosis is summarized in Fig. 1 [108] , have been shown to be regulated by hypoxia [109] [110] [111] [68] . In addition, caveolin-deficient mice show that caveolae and caveolins play a prominent role in various pathological conditions, especially cancer [68] . Interestingly, caveolin-1 has both tumour suppressor and oncogenic properties [112] 
